The article focuses on the phytopharmaceutical drug which includes a purified and standardised fraction with defined minimum four bio-active or phyto-chemical compounds. It mentions the identification and characterization of active fractions rather than single chemical constituents leading to bioactive leads in a multicomponent purified fraction. It also mentions that there is increased awareness for industry-academia partnership in pharmaceutical research.